These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10430042)

  • 1. B-cell responses to myelin basic protein and its epitopes in autoimmune encephalomyelitis induced by Semple rabies vaccine.
    Piyasirisilp S; Hemachudha T; Griffin DE
    J Neuroimmunol; 1999 Aug; 98(2):96-104. PubMed ID: 10430042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA and T-cell receptor gene polymorphisms with Semple rabies vaccine-induced autoimmune encephalomyelitis.
    Piyasirisilp S; Schmeckpeper BJ; Chandanayingyong D; Hemachudha T; Griffin DE
    Ann Neurol; 1999 May; 45(5):595-600. PubMed ID: 10319881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice.
    Kono DH; Urban JL; Horvath SJ; Ando DG; Saavedra RA; Hood L
    J Exp Med; 1988 Jul; 168(1):213-27. PubMed ID: 2456367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semple rabies vaccine: presence of myelin basic protein and proteolipid protein and its activity in experimental allergic encephalomyelitis.
    Javier RS; Kunishita T; Koike F; Tabira T
    J Neurol Sci; 1989 Nov; 93(2-3):221-30. PubMed ID: 2480399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
    Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
    J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T and B cell responses to myelin basic protein and encephalitogenic epitopes.
    Gould KE; Swanborg RH
    J Neuroimmunol; 1993 Jul; 46(1-2):193-8. PubMed ID: 7689588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to peptides of human myelin basic protein in post-rabies vaccine encephalomyelitis sera.
    Ubol S; Hemachudha T; Whitaker JN; Griffin DE
    J Neuroimmunol; 1990 Feb; 26(2):107-11. PubMed ID: 1688875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
    Saoudi A; Simmonds S; Huitinga I; Mason D
    J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein.
    Voskuhl RR; Farris RW; Nagasato K; McFarland HF; Dalcq MD
    J Neuroimmunol; 1996 Nov; 70(2):103-11. PubMed ID: 8898718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response.
    Bischof F; Bins A; Dürr M; Zevering Y; Melms A; Kruisbeek AM
    J Immunol; 2004 Jul; 173(1):600-6. PubMed ID: 15210822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.
    Khoury SJ; Sayegh MH; Hancock WW; Gallon L; Carpenter CB; Weiner HL
    J Exp Med; 1993 Aug; 178(2):559-66. PubMed ID: 7688026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
    Belogurov AA; Kurkova IN; Friboulet A; Thomas D; Misikov VK; Zakharova MY; Suchkov SV; Kotov SV; Alehin AI; Avalle B; Souslova EA; Morse HC; Gabibov AG; Ponomarenko NA
    J Immunol; 2008 Jan; 180(2):1258-67. PubMed ID: 18178866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis.
    Myers KJ; Sprent J; Dougherty JP; Ron Y
    J Neuroimmunol; 1992 Nov; 41(1):1-8. PubMed ID: 1281165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimicry of a 21.5 kDa myelin basic protein peptide by a Maedi Visna virus polymerase peptide does not contribute to the pathogenesis of encephalitis in sheep.
    Davies JM; Watt NJ; Torsteinsdottir S; Carnegie PR
    Vet Immunol Immunopathol; 1996 Dec; 55(1-3):127-39. PubMed ID: 9014312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis.
    Deraos G; Rodi M; Kalbacher H; Chatzantoni K; Karagiannis F; Synodinos L; Plotas P; Papalois A; Dimisianos N; Papathanasopoulos P; Gatos D; Tselios T; Apostolopoulos V; Mouzaki A; Matsoukas J
    Eur J Med Chem; 2015 Aug; 101():13-23. PubMed ID: 26112377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
    J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: functional characteristics and vaccination properties.
    Beraud E; Balzano C; Zamora AJ; Varriale S; Bernard D; Ben-Nun A
    J Neuroimmunol; 1993 Aug; 47(1):41-53. PubMed ID: 7690770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.